Table 2 Binary logistics regression analysis of patients’ demographic and clinical characteristics.

From: Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs

Variables

Remission

HR (95% CI)

P value

ECOG-PS: 2

0.872 (0.684–1.327)

0.971

Difference combined therapy

1.125 (0.927–1.352)

0.073

Difference period therapy

1.188 (0.354–2.1)

0.113

Receptor expression

1.227 (0.248–2.397)

0.093

Number of metastasis organs

0.548 (0.275–0.977)

0.017

Back to article page